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Abstract 
 
Plasma membrane (PM) localization of Ras 
proteins is crucial for transmitting signals upon 
mitogen stimulation. Posttranslational lipid 
modification of Ras proteins plays an important 
role in their recruitment to the PM. Electrostatic 
interactions between negatively charged PM 
phospholipids and basic amino acids found in K-
Ras4B (K-Ras) but not in H-Ras are important for 
permanent K-Ras localization to the PM. Here, we 
investigated how acute depletion of negatively 
charged PM polyphosphoinositides (PPIns) from 
the PM alters the intracellular distribution and 
activity of K- and H-Ras proteins. PPIns depletion 
from the PM was achieved either by agonist-
induced activation of phospholipase C β (PLCβ) or 
with a rapamycin-inducible system in which 
various PI phosphatases were recruited to the PM. 
Redistribution of the two Ras proteins was 
monitored with confocal microscopy or with a 
recently developed bioluminescent energy transfer 
(BRET)-based approach involving fusion of the 
Ras C-terminal targeting sequences or the entire 
Ras proteins to Venus fluorescent protein. We 
found that PM PPIns depletion caused rapid 
translocation of K-Ras but not H-Ras from the PM 
to the Golgi. PM depletion of either 
phosphatidylinositol 4-phosphate (PtdIns4P) or 
PtdIns(4,5)P2, but not PtdIns(3,4,5)P3, was 
sufficient to evoke K-Ras translocation. This effect 
was diminished by deltarasine, an inhibitor of the 
Ras–phosphodiesterase interaction, or by 
simultaneous depletion of the Golgi PtdIns4P. The 
PPIns depletion decreased incorporation of [3H]-
Leucine in K-Ras-expressing cells, suggesting that 
Golgi-localized K-Ras is not as signaling 
competent as its PM-bound form. We conclude that 
PPIns in the PM are important regulators of K-Ras 
mediated signals. 
 
 
The interaction of intracellular signaling 
proteins with the hydrophobic membranes of 
eukaryotic cells is critical for the signaling 
competence of these proteins. In the case of the 
peripheral PM proteins, such interaction with the 
PM can occur via different mechanisms. Proteins 
that contain an amphipathic α-helix or hydrophobic 
loops can directly penetrate into the inner surface of 
the membrane. Others, however, do not contain 
enough clustered hydrophobic amino acids to 
maintain a stable membrane interaction. In this case 
other mechanisms are necessary to attach the 
protein to the PM. Many signaling proteins undergo 
post-translational lipid modifications, attaching a 
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myristoyl, palmitoyl or prenyl group on specific 
amino acid residues. These modifications provide 
the lipophilicity of the proteins ensuring proper PM 
localization (1). 
Ras protein mutations are one of the most 
common causes in cancer and hence have attracted 
a lot of attention. These small globular proteins are 
molecular switches that change conformation upon 
GTP binding relative to their GDP-bound forms 
(2,3). Their C-termini contain their localization 
signal providing for membrane attachment due to 
post-translational modifications. Numerous 
oncogenic mutations of Ras proteins have been 
identified, many of which affect GTP binding of 
these proteins, but naturally occurring mutations in 
the C-terminal anchoring domains have not been 
reported yet, showing the uniquely significant role 
of this conserved essential segment of the Ras 
protein functions (4). H-Ras proteins undergo two 
lipid modifications: in addition to their C-terminal 
prenylation, they are also palmitoylated in their C-
terminal tails (5). In contrast, K-Ras protein contain 
only the prenyl modification and their PM 
anchoring is highly dependent on a polybasic amino 
acid sequence as a ,,second signal” located in their 
C-terminal tail (6). Previous studies have shown 
that changing the positively charged amino acids to 
neutral amino acids by site directed mutagenesis 
can fully abolish the PM localization of the K-Ras 
protein. Such mutated K-Ras proteins show non-
specific endomembrane localization similarly to 
that of proteins that have only a prenyl or myristoyl 
group as targeting signals (7-9). 
At cytoplasmic pH, the cytosolic face of the 
PM is enriched in two types of anionic 
phospholipids: phosphatidylserine (PS) is the most 
abundant anionic phospholipid, amounting to 3-
10% of the total phospholipid pool of the cells (10) 
found in the inner leaflet of the PM. The other is the 
various polyphosphoinositides (PPIns) that account 
less than 1% of total anionic phospholipids (11). 
Although PS is found in a relative high amount in 
the PM providing the bulk negativity for the inner 
leaflet of the membrane (12), its precise role in 
controlling cellular processes is vastly under-
explored. In contrast, the impact of the PPIns in the 
regulation of variety of cellular processes is well 
established. Of the three PPIns phosphatidylinositol 
4-phosphate (PtdIns4P) and phosphatidylinositol 
4,5-bisphosphate (PtdIns(4,5)P2) equally share the 
majority role, whereas phosphatidylinositol 3,4,5-
trisphosphate (PtdIns(3,4,5)P3) is present only in a 
very small amount even in stimulated cells. While 
these lipids have substantial roles in the regulation 
of ion channels, cell motility, vesicular trafficking, 
and they also represent molecular clues for 
targeting signaling proteins to membranes (13-15), 
their contribution to the regulation of some 
important pathways is not fully explored.  
In this study, we investigated how the rapid 
depletion of PM PPIns can regulate the intracellular 
distribution of lipid anchored PM proteins, namely 
the K- and H-Ras proteins. Using a BRET-based 
method suitable to monitor the movement of PM 
bound proteins after they are released from the PM, 
we show the translocation of K-Ras or its isolated 
targeting sequence to either the ER or the Golgi 
upon rapid PM PPIns depletion. The method is 
highly sensitive, can be easily quantified, therefore, 
allows the comparison of the involvement of the 
various PPIns in the PM localization of the Ras 
proteins. This analysis also reveals that PM PPIns 
depletion significantly attenuates the proliferation 
of the cells expressing constitutively active K- but 
not H-Ras mutants, which highlights the different 
functional role of the PPIns dependent PM 
anchoring in K-Ras and H-Ras signaling. 
 
 
Results 
 
Energy transfer-based monitoring of the 
intracellular movement of peripheral proteins 
bound to the cytoplasmic surface of the PM 
We designed several constructs to target the Venus 
protein to the inner leaflet of the PM using targeting 
signal sequences either added to the N- or the C-
termini of the fluorescent protein (Fig. 1A). These 
included the N-terminal 14 amino acids of the Lyn 
kinase, which has a single palmitoyl and a single 
myristoyl modification (Lyn1-14-Venus), the N-
terminal 10 amino acids of the Lck kinase, which 
has a double palmitoyl and a single myristoyl 
residue (Lck1-10-Venus), and the N-terminal 15 
amino acids of the c-Src kinase, which contains 
only a single myristoyl (c-Src1-15-Venus). As for C-
terminal signal sequences, we used the C-terminal 
22 residues of K-Ras modified by prenylation 
(Venus-K-Ras-CAAX), or the C-terminal 22 amino 
acid signal sequence of the H-Ras, which possesses 
double palmitoylation and prenylation (Venus-H-
Ras-CAAX). Notably, in addition to the lipid 
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modification, the targeting sequences of c-Src and 
and K-Ras also contained a number of positively 
charged amino acids. As expected and showed 
before by various reports (14,16,17), transient 
expression of all of these constructs in HEK 293T 
cells labeled the PM (Fig. 1A). Importantly, most 
of the constructs also displayed a small but 
consistent endomembrane localization, the amount 
of which was minimal relative to the total amount 
of the proteins. 
Recently we developed a bioluminescent 
energy transfer (BRET)-based method monitoring 
the proximity of luciferase-tagged PM receptors 
and the Venus protein targeted to the surface of 
various intracellular organelles. This method was 
successfully used to follow the intracellular 
trafficking route of GPCRs from the PM to different 
intracellular compartments (18,19). To investigate 
the dynamic changes of the membrane localization 
of peripheral membrane proteins that bind the PM, 
and follow their intracellular fates, we utilized the 
same approach with some modifications. The most 
important modification was that now we targeted 
the luciferase enzyme itself to the cytoplasmic 
surface of the different intracellular organelles to 
serve as donor and used the Venus protein tagged 
with the various PM-targeting sequences (see 
above) as the acceptor (Fig. 1B). 
Moreover, we used an improved version of 
Renilla luciferase and fused it to well characterized 
resident protein sequences defining various 
organelles. These included targeting sequences of 
TGN38 (N-terminal target of the full length 
protein) for Golgi, TOM70 (N-terminal 1-30 amino 
acids) for mitochondria, Sac1 (C-terminal 521-587 
amino acids) for ER and EEA1 (1253-1411 amino 
acids that corresponds its FYVE-domain) for early 
endosomes (Fig. 1C). To validate proper 
localization, Luciferase enzyme was replaced by 
Cerulean in all of the constructs, and the constructs 
were expressed in HEK 293T cells to confirm their 
proper localization (Fig. 1C). 
 
Acute manipulation of PM PPIns pools 
To achieve the PM PPIns depletion, a previously 
described rapamycin-induced heterodimerization 
system was used (20). In most of the experiments, 
the FKBP-fused version of the bifunctional 
phosphatase, Pseudojanin (PJ) containing a 4- and 
a 5-phosphatase domain (15). FRB was targeted to 
the PM using the targeting sequence of the Lck 
protein (Fig. 2A). When the role of PtdIns(3,4,5)P3 
was studied, low (100 nM) concentration of 
wortmannin was used to inhibit Class I PtdIns 3-
kinase activity.  
 Effects of these manipulations on PM 
PPIns levels were validated using specific 
biosensors based on the following lipid binding 
domains: SidM-2xP4M as the PtdIns4P sensor 
(21), PLCδ1-PH as the PtdIns(4,5)P2 sensor (22) 
and Btk-PH as the PtdIns(3,4,5)P3 sensor (23). As 
shown on Fig. 2B by confocal microscopy in HEK 
293T cells rapamycin-induced PJ recruitment 
resulted in the decrease in both the PtdIns4P and 
PtdIns(4,5)P2 levels. This was confirmed by using 
the more quantitative BRET-based biosensors (24). 
Recruitment of PJ enzymes of various activities 
with 300 nM rapamycin resulted in a rapid decrease 
of the PM PtdIns4P, PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3 (Fig. 2C red curves). Wortmannin 
pretreatment did not affect the PM PtdIns4P, 
PtdIns(4,5)P2, but induced maximal depletion of 
PM PtdIns(3,4,5)P3. Notably, wortmannin 
treatment reduced PM PtdIns(3,4,5)P3 to a lower 
level than the rapamycin-induced depletion of its 
precursor, PtdIns(4,5)P2, indicating that the 
removal of the PtdIns(3,4,5)P3 precursor may not 
have been complete and the inhibition of the PI3Ks 
enzyme is more effective under these conditions. 
Although these results were mostly confirmatory of 
previous similar studies, they were important for 
proper evaluation of the subsequent experiments.  
 
PM PPIns depletion evokes the redistribution of 
the polybasic peripheral proteins from the PM to 
the Golgi 
Hammond et al. have found that peripheral proteins 
containing positively charged amino acids are 
released from the PM after combined PtdIns4P and 
PtdIns(4,5)P2 depletion (15). To investigate this 
phenomenon in further details using the various 
PM-targeted Venus, we initially performed 
confocal measurements. As shown on Fig. 3A, 
depletion of PM PtdIns4P, PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3 level by the addition of rapamycin 
clearly reduced the PM localization of Venus-K-
Ras-CAAX, while the localization of the other PM 
targeted Venus constructs (Lyn1-14-Venus, Lck1-10-
Venus, Venus-H-Ras-CAAX) remained unchanged 
(Fig. 3A). In the case of the c-Src1-15-Venus the 
reduction of PM localization is not so clear, but 
there is a tendency that the fluorescent signal 
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showed an endomembrane pattern upon rapamycin 
treatment (Fig. 3A). 
 To obtain more information about the fate 
of the proteins after their release from the PM, we 
next performed BRET measurement between the 
proteins and various intracellular organelles. First, 
we used HEK 293T cells co-expressing Luc-ER on 
top of the expression of the components of the lipid-
depletion system and the PM–targeted Venus 
proteins. Since the ER has a large surface, we 
reasoned that proteins released from the PM would 
generate a signal with the ER-targeted luciferase. 
As shown on Fig. 3B upon PM PPIns depletion we 
did detect increased energy transfer in cells 
expressing the Venus-K-Ras-CAAX or c-Src1-15-
Venus constructs (2.73x10-2  0.723x10-2 P<0.001, 
1.61x10-2  0.284x10-2 P=0.027, resp.). There was 
no significant change, however, in the case of the 
other PM targeting sequences. 
Next, we investigated whether these two 
targeting motifs can generate energy transfer with 
luciferase targeted to the surface of other 
organelles. As shown in Fig. 3C, releasing Venus-
K-Ras-CAAX from the PM has generated a 
significant increase in the BRET signal in the Golgi 
(9.0x10-2  0.256x10-2 P=0.001) but not in early 
endosomes. In the case of the mitochondria we 
detected a very small, but still significant increase 
(0.712x10-2  0.15 x10-2 P=0.026). c-Src1-15-tagged 
Venus resulted in similar change (data not shown). 
Importantly, we did not detect any interaction 
between Golgi-Luc and Venus-H-Ras-CAAX after 
PM PPIns depletion (Fig. 3D). 
 As an important control experiment, we 
determined that PM PPIns depletion did affect the 
localization of the organelle-targeted luciferases. 
As shown on Fig. S1 confocal microscopy did not 
reveal any detectable change in the localization of 
the constructs (here luciferase was replaced by 
Cerulean). 
 
Translocation of Venus-K-Ras-CAAX from the 
PM to the Golgi happens through the cytoplasm 
and depends on the Golgi PtdIns4P level 
Previous studies have shown that rather than using 
vesicle trafficking the K-Ras proteins move 
between intracellular membranes through binding 
to “solubilizing factors” such as Galectin-3 and 
PDEδ to prevent random attachment to the 
endomembranes (6,25). Structural analysis, showed 
that these transport proteins provide with a 
hydrophobic grove suitable to adopt the 
hydrophobic farnesyl group on the K-Ras protein, 
thereby increasing its water solubility (26-28). To 
test how this process affects the translocation of the 
protein from the PM to the Golgi, we pretreated 
cells with deltarasin, a compound that competes to 
Ras binding by mimicking the structure of farnesyl 
groups (26). Deltarasin treatment significantly 
reduced (from 7.47x10-2  0.218x10-2 to 3.29x10-2 
 0.692x10-2 P=0.005) the appearance of Venus-K-
Ras-CAAX at the Golgi upon PM PPIns depletion 
(Fig. 4A). Confocal images on Fig. 4B also show 
that in deltarasin pretreated COS-7 cells a reduced 
amount of Venus-K-Ras-CAAX reached the Golgi 
upon the rapamycin treatment. Instead, Venus-K-
Ras-CAAX remained bound to intracellular 
vesicular structures. Notably, deltarasine treatment 
alone significantly reduced K-Ras-CAAX Golgi 
interaction (-1.94x10-2  0.374x10-2 P=0.039), 
suggesting that even in resting cells (without PM 
PPIns depletion) there is a rapid cycling of K-Ras-
CAAX tagged proteins between the Golgi and the 
PM (Fig. S2A). 
To confirm that Venus-K-Ras-CAAX can 
exist in the cytoplasm not in a membrane bound, but 
in free, solubilized form, we carried out a simple 
experiment. Cells that expressed Venus-K-Ras-
CAAX were treated with the permeabilization 
agent digitonin allowing the release of small 
cytoplasmic proteins from the cell. As shown on 
Fig. 4D upon the permeabilization Venus-K-Ras-
CAAX also appeared in the membrane of the other, 
non-transfected cells of the culture, supporting the 
hypothesis of the membrane-independent 
cytoplasmic trafficking. This phenomenon was 
never noticed when H-Ras-CAAX was used instead 
of the K-RAS-CAAX (Fig. 4D). 
To examine whether it is the Golgi 
PtdIns4P that recruits the Venus-K-Ras-CAAX 
during its Golgi translocation, we performed BRET 
measurements in which in addition to depletion of 
PM PPIns, the PtdIns4P pool of the Golgi was also 
reduced. To do this, we co-transfected HEK 293T 
cells with plasmids that targeted FRB both to the 
PM and the Golgi for the rapamycin-dependent PJ 
translocation to both compartments (Fig. 4D). As 
shown on Fig. 4D upper plot, concomitant Golgi 
PtdIns4P depletion resulted in a significantly lower 
(from 3.99x10-2  0.422x10-2 to 1.81x10-2  
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0.0704x10-2 P=0.007) translocation of the K-Ras-
CAAX tagged Venus, compared to the case where 
PPIns depletion occurred only at the PM. Control 
measurements of PM PtdIns(4,5)P2 was carried out 
to show that the decrease of the Golgi translocation 
of Venus-K-Ras-CAAX was not due to a lesser PM 
phospholipid depletion (Fig. 4E lower plot). 
 
PM binding of Venus-K-Ras-CAAX depends on 
electrostatic interactions rather than binding to 
specific lipids 
As shown in Fig. 2, rapamycin-induced PJ-
recruitment led to acute depletion of PtdIns4P, 
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 in the PM. To 
investigate whether any of these lipids has a 
specific role keeping the K-Ras-CAAX-tagged 
Venus in the PM, we depleted these PPIns 
individually. 
As shown in Fig. 5A, the robust 
PtdIns(3,4,5)P3 depletion in the PM achieved by 
Wm treatment (see Fig. 2C) did not cause Venus-
K-Ras-CAAX to appear in the Golgi compartment, 
nor did it affect the Golgi translocation response 
following PJ recruitment to the PM. This suggests 
that PM PtdIns(3,4,5)P3 plays a negligible role in 
the stabilization of the Venus-K-Ras-CAAX 
protein at the PM. 
Next, we depleted PM PtdIns4P and 
PtdIns(4,5)P2 separately to examine the 
contribution of these lipids individually to the PM 
localization of the K-Ras. For this, we used PJ 
enzymes inactivated in either its 5-phosphatase 
(FKBP-PJ-4ptase) or 4-phosphatase (FKBP-PJ-
5ptase) activities (15). As shown in Fig. 5B, FKBP-
PJ-5ptase recruitment, which reduced only the PM 
PtdIns(4,5)P2 level (with a slight increase in PM 
PtdIns4P), caused an about 40% reduction (from 
7.67x10-2  0.71x10-2 to 4.58x10-2  1.21x10-2 
P=0.00287) of Venus-K-Ras-CAAX translocation 
to the Golgi when compared to the effect of FKBP-
PJ. Recruitment of the FKBP-PJ-4ptase, which 
reduced only PM PtdIns4P was less effective (85% 
reduction), but still caused a significant increase 
(1.25x10-2  0.041x10-2 P=0.003) of K-Ras-CAAX 
Golgi appearance (Fig. 5B). 
 
The effect of PM PPIns depletion on the 
intracellular trafficking of full-length K- and H-
Ras proteins 
In the previous experiments, we examined the 
isolated targeting sequences of the Ras proteins. To 
study the behavior of the full-length Ras proteins, 
we created N-terminally Venus-tagged versions of 
the full-length K- and H-Ras proteins, and 
investigated their movements under conditions of 
PPIns manipulations. In these experiments, the 
constitutively active forms G12V of both Ras 
proteins were used. As shown on Fig. 6, the full-
length proteins showed the same changes in 
response to PPIns depletion as their isolated 
targeting sequences examined both by confocal 
microscopy (Fig. 6A) and BRET (Fig. 6B and C) in 
HEK 293T cells (1.34x10-2  0.275x10-2 P=0.049, 
3.56x10-2  0.567x10-2 P=0.02, resp.). Wild type or 
dominant negative forms of the Ras proteins, 
behaved the same way indicating that the 
translocation process is independent of the activity 
state of these proteins (Fig. S3). 
 
K-Ras moves to the Golgi during Gq-coupled or 
EGF receptor activation 
After testing Ras distribution using the artificial 
PPIns manipulations, we wanted to determine how 
PPIns changes that occur during more physiological 
conditions, namely during Gq-coupled receptor 
activation affect the intracellular distribution of the 
K-Ras protein. For this, M3 muscarinic receptors 
(M3R) were expressed in HEK 293T cells, together 
with either Venus-K-Ras-CAAX or Venus-K-Ras 
G12V constructs and the Golgi-Luc protein to 
examine K-Ras translocation to the Golgi 
membrane in BRET measurements. The M3R 
agonist, carbachol was used to stimulate PLC 
activation. Distribution of the Venus-K-Ras-CAAX 
construct was also examined with confocal 
microscopy, using transiently transfected COS-7 
cells. As shown in Fig. 7A, carbachol treatment 
caused a moderate transient elevation in the Golgi 
appearance of either Venus-K-Ras-CAAX or the 
full Venus-K-Ras G12V protein (1.28x10-2  
0.0521x10-2 P=0.013, 0.759x10-2  0.106x10-2 
P=0.005, resp.), which was more pronounced with 
the Venus-K-Ras-CAAX construct. Pretreatment of 
the cells with A1, an inhibitor of the type-III PI4Kα 
kinase (PI4KA), which prevents PtdIns4P and 
PtdIns(4,5)P2 resynthesis, resulted in a more 
sustained effects. Similar changes were observed in 
COS-7 cells using confocal microscopy (Fig. 7B). 
Notably, A1 treatment increased K-Ras-CAAX 
Golgi interaction (1.56x10-2  0.167x10-2 P=0.049), 
suggesting that even in resting cells PM PtdIns4P 
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depletion alone can evoke translocation of K-Ras-
CAAX to the Golgi (Fig. S2B). 
 Previously we showed that stimulation of 
HEK 293T cells with EGF decreases PM 
PtdIns(4,5)P2 level by activating the generation of 
PtdIns(3,4,5)P3 and IP3 by PI3 kinases and PLCγ, 
respectively (24). Interestingly the latter effect 
could not abolished by low concentration of Wm 
(100 nM) (24). To examine whether this decrease 
of PM PtdIns(4,5)P2 can have an impact on the 
distribution of K-Ras, we decided to measure 
arrival of the Venus-K-Ras-CAAX to the Golgi. 
Stimulation of endogenous EGF receptors of HEK 
cells by 100 ng/ml EGF failed to cause a detectable 
translocation from the PM to the Golgi (data not 
shown). However, when cells were co-transfected 
with the EGF receptor, EGF stimulation caused 
translocation of Venus-K-Ras-CAAX from the PM 
to the Golgi in a similar way, as did M3R 
stimulation (0.665x10-2  0.293x10-2 P=0.002) 
(Fig. 7C). Similarly, this effect was even larger 
when PI4KA was inhibited with A1 consistent with 
the notion that depletion of plasma membrane 
PtdIns4P and PtdIns(4,5)P2 together liberates K-
Ras, which is then recruited to the Golgi by 
PtdIns4P in that compartment (Fig. 7C). In contrast, 
inhibition and subsequent depletion of the PM 
PtdIns(3,4,5)P3 did not enhanced the translocation 
(Fig. 7C), which is also consistent with its minor 
effect on the PM recruitment of K-Ras (Fig. 5A). 
 
PM PPIns depletion attenuates K-Ras but not H-
Ras induced cell proliferation 
Ras proteins control numerous cellular processes 
ranging from cell growth to differentiation and cell 
survival (29). To investigate the functional 
consequences of K-Ras translocation to the Golgi 
after PM PPIns depletion, we carried out a 24 hour 
[3H]-Leucine incorporation assay to evaluate the 
rate of the protein synthesis as marker of cell 
proliferation. 
First, the proliferative effect of the 
constitutive active mutation of Ras was examined. 
Constitutive active G12V and dominant negative 
S17N forms of the K- and H-Ras proteins were 
expressed transiently in COS-7 cells. As expected, 
cells expressing the activating Ras mutants showed 
significantly larger Leucine incorporation 
compared to those expressing the dominant 
negative forms (P<0.001) (Fig. 8A). This increased 
protein synthesis was used as a sign of increased 
proliferation caused by the active Ras mutants. 
Next, we examined how the PM PPIns depletion 
affects the ability of active Ras to induce 
proliferation. Again, PM PPIns depletion was 
achieved using recruitment of FKBP-PJ. Since 
rapamycin, an mTOR inhibitor was used for 
recruitment; we used the catalytically inactivated 
FKBP-PJ enzyme as control (15). As shown on Fig. 
8B, active K-Ras increased the [3H]-Leucine 
incorporation even in the presence of 100 nM 
rapamycin, although its effect was reduced 
(compare Fig. 8A and B). PM PPIns depletion did 
not affect the already low [3H]-Leucine 
incorporation in cells expressing the dominant 
negative form of K-Ras S17N, but had a significant 
inhibitory effect (P=0.003) in cells expressing the 
active form of K-Ras G12V. Notably, PPIns 
depletion did not change the proliferative effect of 
H-Ras G12V. This was in agreement with the 
earlier data showing that H-Ras G12V PM 
localization does not depend on the PM PPIns. 
These experiments showed that only the PM-
localized Ras is competent in signaling to 
proliferation and the Golgi-associated form is 
unable to induce the same changes under PPIns-
depleted conditions. 
 
 
Discussion 
 
PM localization plays a fundamental role in 
the function of many intracellular signaling 
proteins. Several factors determine PM localization 
of a protein, some of which are intrinsic to the 
protein, such as the presence of hydrophobic lipid 
modifications or transmembrane segments. Some 
of the interactions, however, rely upon specific 
lipid components of the membrane, such as PPIns 
or simple electrostatic interactions provided by 
acidic lipids, such as PtdSer. In this study, we 
investigated how depletion of negatively charged 
PPIns can acutely regulate the PM association and 
intracellular distribution of selected peripheral PM 
proteins. We focused on two members of the Ras 
family, K-Ras and H-Ras. The C-terminus of both 
of these proteins undergo prenylation, but this alone 
is not sufficient for stable PM interaction. In the 
case of K-Ras electrostatic interactions between 
positively charged residues located within the C-
terminal tail of the molecule and negatively charged 
phospholipids of the PM is required for PM 
 JBC
K-Ras trafficking 
 
7 
 
localization. In contrast, H-Ras, has two additional 
palmitoylations in its C-terminus that ensures PM 
localization. These features have major impact on 
the different signaling properties of these Ras 
proteins (30,31). 
In this study we used an adaptation of our 
recently developed BRET system to have a more 
quantitative assessment of the role of the individual 
PPIns on K-Ras and H-Ras PM localization. 
Moreover, we also developed a method to have a 
quantitative assessment of which intracellular 
membranes Ras molecules will interact with once 
released from the PM. We combined these BRET 
measurements with the controlled elimination of 
PtdIns4P and PtdIns(4,5)P2 using the rapamycin-
inducible membrane recruitment of the bifunctional 
artificial PPIns phosphatase, pseudojanin (PJ) (15). 
Using this system, we confirmed previous findings 
(13-15) that both PtdIns4P and PtdIns(4,5)P2 were 
important for PM localization of K-Ras, but 
PtdIns(4,5)P2 was more important, and 
PtdIns(3,4,5)P3 played little if any roles. This 
discrepancy could be explained with the generation 
of stronger local electric field by PtdIns (4,5)P2, 
especially, if it is present in clusters in the PM (32-
34), or it is caused by the insufficient PM PtdIns4P 
depletion when PJ-4ptase is used instead of PJ 
(compare PM PtdIns4P measurement on Fig2C and 
Fig 5B). Recently, based on the ability to form 
long-lived salt bridges the distinguished role of 
PtdIns(4,5)P2 was also shown (35). 
 Although PPIns appear to be the most 
important in K-Ras PM recruitment, the role of 
PtdSer on K-Ras localization has been reported (36-
39). Although PS only carries a single negative 
charge it is present in the inner leaflet of the PM in 
relatively high amount (34), therefore, could 
contribute to the localization of proteins containing 
basic surface patches. Indeed, it was found that by 
decreasing the PM PtdSer level (measured by 
LactC2 (12)), 7-oxostaurosporine or fendiline 
could effectively reduce the amount of the PM 
bound K-Ras in MDCK cells (36,37,39). 
Unfortunately, a long-term exposure (at least 24-
hour) to these inhibitors was required to achieve the 
lipid change and several other changes could occur 
during this treatment regime. Our effort to acutely 
reduce PM PtdSer has not been successful so far 
and therefore we could not assess the role of PS in 
K-Ras PM localization. These efforts are still being 
continued in our laboratory. 
 An important new aspect of our study was 
to follow the fate of the K-Ras protein once it was 
released from the PM during PPIns depletion. 
Again, using a BRET analysis that monitors the 
appearance of the K-Ras protein in membranes of 
the ER, Golgi, endosomes or mitochondria, we 
showed that K-Ras rapidly appears in the Golgi and 
to a smaller extent in the ER, but not in the 
endosomes after being released from the PM. In 
case of the mitochondria there is a slight increase of 
the energy transfer between the mitochondria-
targeted luciferase and the Venus-K-Ras-CAAX, 
but it is negligible compared to the Golgi, and 
reflects the appearance of the Venus in the 
cytoplasm. According to the current views, after 
released from the PM K-Ras binds transport 
proteins such as Galectin-3 and PDE that keep it 
in the cytosol. Our results are consistent with this 
idea since the Golgi translocation of the Venus-K-
Ras-CAAX protein was prevented by treatment 
with deltarasine, a compound that mimics the 
farnesyl groups and competes for K-Ras binding of 
the transport molecules. Moreover, Venus-K-Ras-
CAAX can leave the cytoplasma when cells are 
permeabilized. Interestingly, when the cytoplasmic 
transport is inhibited Venus-K-Ras-CAAX appears 
on the surface of intracellular vesicles, probably 
because they are negatively charged by PtdIns3P 
and close to the PM, therefore, are able to trap 
Venus-K-Ras-CAAX. Since the electrostatic 
interaction seems to be major determinant of the 
membrane binding even in case of endomembranes, 
it is not surprising that PtdIns4P depletion of Golgi 
does also not favor the localization of the proteins 
in the Golgi. 
Could there be a physiological significance 
of the Golgi localization of K-Ras? There are many 
examples in the literature that small G-proteins 
proteins are capable of initiating signaling events 
from endomembranes, including the Golgi. It has 
been reported that Ras proteins can be activated at 
the Golgi (40,41), and are able to initiate 
proliferation signals through the activation of ERK 
(42). These reports, however, referred to H- and N-
Ras, but not K-Ras4B, since during its intracellular 
trafficking K-Ras is not found in the Golgi (6). 
However, a potential significance of the 
tranlocation of K-Ras from the PM to the 
endomembranes including ER and Golgi could be 
that Ras signaling might be switched on in these 
other localizations, if RasGRPs can control their 
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activation state (43,44). Bivona et al described the 
PKC-dependent translocation of K-Ras from the 
PM to endomembranes including the Golgi and the 
mitochondria by a mechanism, which included the 
phosphorylation of serine residues on the C-
terminal tail of K-Ras, disrupting the electrostatic 
interaction between the protein and the membrane 
(45). However, we could not detect the appearance 
of Venus-K-Ras-CAAX either in the Golgi or in the 
mitochondria upon PMA treatment. This apparent 
discrepancy could be explained with the different 
stimulation regime in the Bivona studies and ours; 
to activate PKC they used bryostatin and since 
PMA alone was found to be ineffective, they also 
added ionomycin, which by increasing Ca2+ could 
have evoked PPIns depletion. 
 The proliferating effect of the Ras proteins 
depends on the activation of three distinct 
pathways: 1.) active Ras can elevate PM 
PtdIns(3,4,5)P3 levels due to activation of PI3K 
enzymes and therefore activates Akt signaling 2.) it 
can directly activate the MAPK cascade via 
activation of Raf proteins and 3.) it can activate the 
Ral-GDS protein, which than triggers the 
conversation of GDP bound inactive Ral proteins to 
GTP bound active form (3). Although this latter 
pathway is less established compared to the plenty 
of literature on the first two pathways, its 
significance is increasing as a major factor in the 
transforming ability of the Ras proteins (31,46). We 
used the 24 hour [3H]-Leucine incorporation as a 
measure of Ras-induced proliferation after 
expression of the various Ras proteins either in their 
active G12V or inactive S17N forms. To test the 
effect of PPIns depletion on Ras signaling we used 
the rapamycin-recruitable PJ enzyme. These 
experiments showed that K-Ras but not H-Ras 
signaling (as it translates to [3H]-Leucine 
incorporation) was highly dependent on PM PPIns 
suggesting that it is the PM-bound form that is 
important for signaling and increased Golgi 
association does not support a proliferative effect. 
Importantly in cells that expressed oncogenic Ras, 
[3H]-Leucine incorporation was increased even in 
the presence of 100 nM rapamycin, which inhibits 
mTOR signaling (47,48). In contrast to K-Ras, the 
increased proliferation evoked by H-Ras expression 
did not depend on PM PPIns (including 
PtdIns(3,4,5)P3). This finding was somewhat 
unexpected in light of numerous reports showing 
that PPIns are required for the normal function of 
several members of the MAPK pathway (49,50). 
We also found that ERK phosphorylation was 
reduced by PM PPIns depletion (G. Gulyás and P. 
Várnai unpublished observations) raising the 
possibility that the proliferative effects of K-Ras are 
mediated primarily by the Ral pathway. Although 
there is a paper suggesting that the Ral pathway is 
originated from the Golgi (51), it is widely accepted 
that active PM-bound Ras proteins can activate cell 
proliferation through the Ral-TBK1 pathway (52). 
Additionally, we can find examples in the literature 
that palmitoylation could also occurs on further 
cysteine residues away from the terminal cysteine 
within the C-terminal tail domain, which strengthen 
the PM anchoring of Ral, and prevent the 
detachment of this molecule from the PM after PM 
PPIns depletion, as could be seen in the case of the 
H-Ras protein (53,54). 
 Lastly, there is a plethora of literature 
concerning the segregation of the various PM 
targeting sequences in lateral domains of the PM 
often referred to as rafts (16,55). However, there is 
a significant amount of controversy surrounding 
this topic (56,57). CAAX domains with polybasic 
residues are often used to target domains outside of 
rafts, whereas the Lyn domain is used to target rafts 
(58). Notably, however, it was suggested that 
PtdIns(4,5)P2 is found in rafts (59), which is where 
CAAX domains with polybasic sequences would 
be enriched. The distribution of PtdIns(4,5)P2 or its 
protein binding partners to specialized PM domains 
could not be substantiated by several credible 
efforts (60,61). This topic is worth mentioning 
because of the significant literature on the 
distribution of the various Ras proteins into 
specialized PM domains designated as rafts (62-
64). Unfortunately, our studies were unable to shed 
any light on this topic and several efforts in our 
group failed to detect a difference between the 
ability of any of these PM targeting sequences to 
access PPIns when used to recruit PPIns modifying 
enzymes (P. Várnai, G. Gulyás and T Balla 
unpublished observations). 
 In summary, these studies were aimed at 
assessing the role of PM PPIns in the localization 
of various PM targeting sequences using a BRET-
based method for quantitative assessment. In 
agreement with the literature, we found that 
sequences that use polybasic stretches in addition to 
lipid modifications depend on PPIns for membrane 
attachment by principle of electrostatic interactions 
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rather than specific PPIns binding. Using the K-Ras 
protein as an example, we also followed the 
intracellular fate of the protein and showed that it 
associated with the Golgi in a PtdIns4P-dependent 
manner once released from the PM, but this Golgi-
associated pool was unable to maintain the 
proliferative effect of the K-Ras protein.  
 
 
Experimental procedures 
 
Materials 
Molecular biology reagents were purchased from 
Fermentas (Vilnius, Lithuania). For the polymerase 
chain reaction, the Pfu Turbo Hotstart polymerase 
was used (Agilent Technologies; Santa Clara, CA). 
Cell culture dishes, 24- and 96-well plates were 
obtained from Greiner (Kremsmunster, Austria). 8-
well -Slides (Cat. No.: 80826) for confocal 
experiments were obtained from IBIDI 
(Martinsried, Germany). Coelenterazine h was 
purchased from Regis Technologies (Morton 
Grove, IL). Lipofectamine 2000 was from 
Invitrogen (Carlsbad, CA). Rapamycin and PIK-93 
were obtained from Selleckchem (Houston, TX). 
GeneCellin transfection reagent was from 
BioCellChallenge (Toulon, France). Deltarasine 
was purchased from Cayman Chemicals (Ann 
Arbor, MI). Unless otherwise stated, all other 
chemicals and reagents were purchased from Sigma 
(St Louis, MO). 
 
DNA constructs 
To create the various PM targeted Venus 
constructs, the targeting sequences of the following 
proteins were synthetized: the N-terminal 14 amino 
acids (AA) of Lyn (Lyn1-14, accession number: 
NM_002350.3), the N-terminal 10 AA of Lck 
(Lck1-10, accession number: NM_005356.4), the N-
terminal 15 AA of c-Src (c-Src1-15, accession 
number: NM_005417.4), and the C-terminal 22 AA 
both of K-Ras4B, and H-Ras proteins (K-Ras-
CAAX, accession number: NM_004985; H-Ras-
CAAX, accession number: NM_005343, 
respectively). The fragments were then inserted 
into monomeric Venus (containing the A206K 
mutation (16)) encoding N1 vector using the NheI 
and BglII enzymes in the case of the N-terminal 
targeting sequences, or into C1 plasmid using the 
EcoRI and BamHI sites in the case of the C-
terminal Ras sequences. The following linkers were 
applied by these constructs: 
DPTRSRAQASNSDPPVAT in the case of the 
Lyn1-14-Venus, 
NNNNDPTRSRAQASNSDPPVAT was used both 
by Lck1-10-Venus and c-Src1-15-Venus (17), and 
NEQRSRAQASNS in the case of the Ras 
constructs. The fluorescent Citrine tagged full-
length K-Ras4B G12V (accession number: 
NM_004985) and the wild type or G12V mutant H-
Ras (accession number: NM_005343) encoding 
plasmids were a kind gift from John F Hancock. To 
create our monomeric Venus tagged versions, the 
sequences of the Ras proteins were amplified using 
PCR, and the fragments were cloned into 
monomeric Venus containing C1 vectors using the 
YSDLELTTMYPYDVPDYA linker in both 
proteins. The missing mutant versions of the Ras 
proteins (K-Ras wt, K-Ras S17N, and H-Ras S17N) 
were created using site directed mutagenesis. 
 To create the various endomembrane 
targeted Luciferase constructs, the targeting 
sequences or the full-length forms of the following 
proteins were used: TOM70 (accession number: 
X05585.1), TGN38 (accession number: 
BC008461), Sac1 (accession number: 
NM_001179777) and EEA (Fyve domain; 
accession number: BX648463) for mitochondria, 
Golgi, endoplasmic reticulum and early endosome 
targeting, respectively. The N-terminal coding 
sequence of the first 30 AA of the TOM-70 protein 
was synthetized, and then was ligated into super 
Renilla luciferase (65) containing N1 plasmid, 
using the NheI and BglII enzyme pairs. The 
sequences of the TGN38 (66), Sac1 (67) or EEA1 
(68) were used earlier. The proper fragments of 
these proteins were amplified with polymerase 
chain reaction, then were inserted into super Renilla 
Luciferase containing N1 vector using NheI and 
BglII enzymes in the case of the TGN38-Luciferase 
construct or into super Renilla Luciferase 
containing C1 vector using EcoRI and BamHI sites 
by Luc-ER and Luciferase-EEA1-FYVE 
constructs. The following linkers were applied by 
these constructs: DPTRSRAQASNSDPPVAT was 
used both by TOM70 and TGN38, whereas the 
SGLRSRAQASNSRV and the RSRAQASNSRV 
sequence was used in the case of the Luciferase-
Sac1 and Luciferase-EEA1-FYVE proteins, 
respectively. 
 The rapamycin inducible lipid depletion 
system, applied for the PM PPIns depletion (24), 
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and the TGN38-FRB-mRFP, which were used for 
recruiting our cytoplasmic phosphatase to the Golgi 
(66), were described earlier. The specific BRET-
based lipid-sensors and the fluorescently tagged 
versions of either SidM-2x-P4M or PLC1-PH 
constructs or luciferase tagged versions of the 
PLC1-PH domain were also previously used (24).  
 Wild type human M3 cholinergic receptor 
(N-terminal 3x-hemagglutinin tagged) was 
obtained from S&T cDNA Resource Center (Rolla, 
MO). The human EGF receptor was described 
earlier (24). 
 
Cell culture 
HEK 293T and COS-7 cells (ATCC, Manassas, 
VA) were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM, Lonza 12-604) 
supplemented with 10% fetal bovine serum, 50 
U/ml penicillin and 50 µg/ml streptomycin in a 5% 
humidified CO2 incubator at 37°C in 10 cm tissue 
culture plastic dishes. 
 
Bioluminescence Resonance Energy Transfer 
(BRET) measurements 
For BRET measurements HEK 293T cells were 
trypsinized and plated on poly-L-lysine-pretreated 
(0.001%, 1 hour) white 96-well plates at a density 
of 7x104 cells/well together with the indicated DNA 
constructs (0.15-0.2 µg total DNA/well) and the 
cell transfection reagent (1.5 μl/well GeneCellin) in 
Opti-MEM reduced serum medium (Gibco). After 
6 hours 100 μl/well DMEM containing serum and 
antibiotics was added. Measurements were 
performed 25-26 hours after transfection. Before 
the measurements, the medium over the cells was 
changed to a medium (50 µl) containing 120 mM 
NaCl, 4.7 mM KCl, 1.2 mM CaCl2, 0.7 mM 
MgSO4, 10 mM glucose, and 10 mM Na-HEPES, 
pH 7.4. Measurements were performed at 37°C 
using a Thermoscientific Varioskan Flash Reader 
(PerkinElmer). The measurements started with the 
addition of the cell permeable luciferase substrate, 
coelenterazine h (40 µl, final concentration of 5 
µM), and counts were recorded using 485 and 530 
nm emission filters. Detection time was 500 ms for 
each wavelength. The indicated reagents were also 
dissolved in modified Krebs–Ringer buffer and 
were added manually in 10 µl. For this, plates were 
unloaded, which resulted in an interruption in the 
recordings. All measurements were done in 2-4 
biological replicates. By the measurements of the 
PM lipid levels, BRET ratios were calculated by 
dividing the 530 nm and 485 nm intensities, and 
normalized to the baseline. Since the absolute ratio 
values depended on the expression of the sensors in 
case of the intermolecular inositol lipid sensors the 
resting levels were considered as 100%, whereas 
the 0% was determined from values of those 
experiments where cytoplasmic Renilla luciferase 
construct was expressed alone. In the case of the 
interaction experiments between the Venus tagged 
PM-targeted constructs and Luciferase tagged 
endomembrane targeted constructs, the difference 
of the BRET ratios was calculated between 
rapamycin (300 nM) or carbachol (10 M) treated 
and vehicle (DMSO, or distillated water) treated 
cells, respectively. 
 
Confocal microscopy 
HEK 293T cells at a density of 3x104 cells/well or 
COS-7 cells at a density of 2x104 cells/well were 
cultured on IBIDI 8 well Slides in Dulbecco’s 
modified Eagle’s medium (DMEM, Lonza 12-604) 
supplemented with 10% fetal bovine serum, 50 
U/ml penicillin and 50 µg/ml streptomycin at 37°C. 
After one day, the culture medium was changed to 
200 µl transfection solution containing the 
indicated DNA constructs (0.2 µg total DNA/well) 
and 0.33 µl/dish Lipofectamine 2000. After 6 
hours, the transfection solution was changed to 300 
µl supplemented DMEM culture medium. Confocal 
measurements were performed 24-26 hours after 
transfection at room temperature in a modified 
Krebs-Ringer buffer described above, using a Zeiss 
LSM 710 scanning confocal microscope and a 
63x/1.4 oil-immersion objective. Post-acquisition 
picture analysis was performed using Fiji and 
Photoshop (Adobe) software’s to expand to the full 
dynamic range but only linear changes were 
allowed. 
 
Permeabilization measurements 
HeLa cells were cultured on 25 mm No. 1.5 glass 
coverslips (2×105 cells/dish) and transfected with 
Venus-K-Ras-CAAX or Venus-H-Ras-CAAX 
constructs (0.5 μg DNA/dish) using 2 μl/dish 
Lipofectamine 2000 for 24 h. Confocal 
measurements were performed at room temperature 
in an intracellular medium containing 117 mM KCl, 
6 mM NaCl, 1 mM KH2PO4, 10 mM K+-MOPS, 2 
mM EGTA, 0.5 mM MgCl2 and 100 nM CaCl2, pH 
7.1; using a Zeiss LSM 710 confocal microscope 
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and a 63x/1.4 oil-immersion objective. For the 
permeabilization 25 g/ml digitonin was applied. 
 
[3H]-Leucine incorporation assay 
The effect of PM lipid depletion on protein 
synthesis in COS-7 cells was evaluated by a [3H]-
Leucine incorporation assay. 5×104 cells were 
seeded in poly-L-lysine-pretreated (0.001%, 1 
hour) 24-well plates and left to adhere overnight at 
37°C. The cells transfected with plasmids and after 
1 day the cells were incubated with serum-free 
DMEM for 6 hours. The quiescent COS-7 cells 
were further incubated in serum-free DMEM 
containing 1 μCi/ml [3H]-Leucine (American 
Radiolabeled Chemicals, Saint Louis, MO, USA) 
with or without 100 nM rapamycin (repeated in 
every 8 hours). After 24 hours of incubation the 
plates were placed on ice, the cells were washed 
twice with ice-cold PBS, and incubated for 30 min 
in cold trichloroacetic acid (5%). The fixed cells 
were then washed with PBS and dissolved in 0.5 M 
NaOH for 30 min. Finally, the lysed cells were 
transferred to scintillation vials containing 10 ml of 
OptiPhase HiSafe3 (Perkin Elmer, Waltham, MA, 
USA). The radioactivity was counted by Beckman 
LS5000 TD liquid scintillation counter.  
 
Statistical analysis 
For the statistical analysis of BRET ratio data, 
paired t-test was used to compare the mean of the 
last three data points before and after the 
stimulation of the individual curves. When two 
separate curves were compared, unpaired t-test was 
also performed on the means of the last three data 
points of the curves after the stimulation. When 
three separate curves were compared, one-way 
ANOVA was used followed by Holm-Sidak all 
pairwise multiple comparison method on the means 
of the last three data points of the curves after the 
stimulation. To investigate the effects of the 
different Ras mutants and/or the PM PPIns 
depletion system in the [3H]-Leucine incorporation 
assay, two-way ANOVA followed by Holm-Sidak 
all pairwise multiple comparison method was used. 
Statistical analysis was performed using SigmaStat 
3.5 program (Systat Software Inc., San Jose, CA, 
USA). 
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Figure legends 
 
Figure 1. Constructs and molecular approach used in the study 
(A) N- or C-terminal target sequences of various proteins were used to generate PM localized Venus 
proteins. The panel on the top shows the targeted Venus proteins on a schematic drawing. The table 
demonstrates the sequences and the type of occurred lipid modifications of the applied targeting signals. 
The amino acids are highlighted in the sequences where the distinct modifications befall. Palmitoylation 
(blue) occurs on cysteine residues without a preference of placement, myristoylation (green) happens 
always on the N-terminal glycine residues after the first methionine, prenylation (brown) occurs on the C-
terminal half of the proteins within the CAAX domain. Polybasic cluster regions are highlighted in red by 
the c-Src1-15 and K-Ras-CAAX constructs. Confocal images reveal the intracellular localization of the PM 
targeted Venus proteins transiently expressed in HEK 293T cells.  
(B) Schematic illustration of the proposed BRET measurements used to follow the intracellular trafficking 
of the PM bound Venus constructs after their release from the PM. 
(C) Localization sequences or full length proteins were used to target the Luciferase enzyme to the 
cytoplasmic surface of various endomembrane (EM) compartment (Golgi: trans-Golgi compartment, mito: 
mitochondrium, ER: endoplasmic reticulum, EE: early endosome). In order to verify their proper 
endomembrane localization with confocal microscopy, HEK 293T cells were transiently transfected with 
constructs, in which luciferase was replaced by Cerulean. 
 
Figure 2. PM PPIns depletion achieved via rapamycin induced recruiting of the bifunctional PPIns 
phosphatase Pseudojanin (PJ) or by using the PI3K inhibitor wortmannin 
(A) Schematic representation of the PM PPIns depletion system. After rapamycin treatment, the 
cytoplasmic, FKBP-fused bifunctional phosphatase, PJ, binds to the PM anchored FRB. The recruitment of 
PJ is expected to cause a rapid degradation of the PM PPIns, resulting low levels of polyphosphorilated 
forms (PtdIns4P, PtdIns(4,5)P2, PtdIns(3,4,5)P3) and concomitant elevation of phosphatidyl inositol 
(PtdIns). Wortmannin (100 nM) inhibits PI3K activity, suitable to prevent the phosphorylation of 
PtdIns(4,5)P2 to PtdIns(3,4,5)P3. 
(B) Monitoring of the PM PPIns levels using fluorescently tagged specific lipid binding domains, as lipid 
sensors. The confocal images were collected from transiently transfected HEK 293T cells expressing the 
proteins of the lipid depletion system (PM-FRB and mRFP-FKBP-PJ) and the specific lipid sensors: SidM-
2xP4M tagged with Cerulean (left) and the PLCδ1-PH (middle) domain tagged with Venus are suitable to 
recognize PM PtdIns4P and PtdIns(4,5)P2, respectively. After rapamycin (300 nM) treatment, the 
cytoplasmic bifunctional phosphatase, PJ, is recruited to the PM, whereas the lipid binding domains are 
released from the PM indicating the effective PM PPIns depletion. The images were collected before and 
after the addition of rapamycin (300 nM, 5 min). Note that the SidM-2xP4M domain recognize PtdIns4P 
pools throughout the cells, therefore it become mostly Golgi localized after depleting PM PtdIns4P pools. 
Cells are representatives of at least ten measurements carried out in three independent experiments. 
(C) Monitoring of the PPIns levels using recently developed specific BRET-based biosensors capable to 
measure PM lipid levels (24). The measurements were carried out on transiently transfected HEK 293T 
cells expressing the proteins of the depletion system (PM-FRB and mRFP-FKBP-PJ) and the various 
biosensors: L10-Venus-T2A-Luc-SidM-2xP4 for PM PtdIns4P, L10-Venus-T2A-PLCδ1-PH-Luc for PM 
PtdIns(4,5)P2 and L10-Venus-T2A-Btk-PH-Luc for PM PtdIns(3,4,5)P3 measurements. Wortmannin (Wm) 
was applied in a concentration of 100 nM, in which it inhibits PI3 but no PI4 kinases. The lipid depletion 
system was activated by 300 nM rapamycin. BRET ratio values were normalized by considering the resting 
ratio as 100% and the complete lack of energy transfer as 0% (see details of the calculation in Materials 
and Methods). Data are means ± SEM of three independent experiments. 
 
Figure 3. Effect of PM PPIns depletion on the rearrangement of various PM-targeted Venus proteins 
(A) Monitoring of the translocation of various PM targeted Venus constructs in transiently transfected HEK 
293T cells also expressing the proteins of the lipid depletion system (PM-FRB and mRFP-FKBP-PJ). 
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Confocal images were taken before and after the rapamycin treatment (300 nM 5 min). Cells are 
representatives of at least ten measurements carried out in three independent experiments. 
(B-D) BRET measurements to examine the interaction between various PM targeted Venus proteins and 
endoplasmic reticulum targeted Luciferase construct (Luc-ER) (B), between K-Ras-CAAX tagged Venus 
and early endosome (Luc-EE), mitochondria (Mito-Luc) and trans-Golgi (Golgi-Luc) targeted Luciferase 
constructs (C) and between H-Ras-CAAX tagged Venus and trans-Golgi targeted Luciferase construct 
(Golgi-Luc) (D). The measurements were carried out on transiently transfected HEK 293T cells also 
expressing the proteins of the depletion system (PM-FRB-mRFP and mRFP-FKBP-PJ). The lipid depletion 
system was activated by 300 nM rapamycin. BRET ratio values are expressed as difference between 
rapamycin treated and vehicle (DMSO) treated cells. Data are means ± SEM of three independent 
experiments. Statistical analysis were performed using t-test to compare the mean of the last three data 
points before and after the stimulation *p < 0.05, ***p < 0.001; ns, non-significant. 
 
Figure 4. Investigation of the travel route of the K-Ras-CAAX tagged Venus protein to the Golgi, and 
evaluation of the significance of the PtdIns4P content of this membrane in the translocation process 
(A) Interaction between the Venus-K-Ras-CAAX and Golgi-Luc proteins by BRET was measured in HEK 
293T cells also expressing the proteins of the depletion system (PM-FRB-mRFP and mRFP-FKBP-PJ). 
Lipid depletion was activated by 300 nM rapamycin. Deltarasine pretreatment (10 μM, 10 min) was used 
to competitively inhibit the binding of the Venus-K-Ras-CAAX proteins to their solubilizing factor 
molecule PDEδ, which promotes their trafficking procedure. BRET ratio values are expressed as difference 
between rapamycin treated and vehicle (DMSO) treated cells in the case of both the untreated or deltarasine 
pretreated cells. Data are means ± SEM of three independent experiments. Statistical analysis were 
performed using t-test (*p < 0.05, **p < 0.01). 
(B) Intracellular distribution of Venus-K-Ras-CAAX was examined by confocal microscopy in COS-7 cells 
also expressing the proteins of the lipid depletion system (PM-FRB and mRFP-FKBP-PJ). The images were 
collected before and 5 min after the addition of 300 nM rapamycin. Cells are representatives of at least ten 
measurements carried out in three independent experiments. 
(C) Intracellular distribution of Venus-K-Ras-CAAX was examined by confocal microscopy in COS-7 cells 
also expressing the proteins of the lipid depletion system (PM-FRB and mRFP-FKBP-PJ). Deltarasine 
treatment of the cells (10 μM, 5 min) was followed by the activation of the lipid depletion system by adding 
rapamycin (300 nM, 5 min). Note the increased number of intracellular vesicles instead of the Golgi 
localization of Venus-K-Ras-CAAX. Cells are representatives of at least six measurements carried out in 
three independent experiments. 
(D) The effect of PM permeabilization was examined in HeLa cells transiently expressing Venus-K-Ras-
CAAX or Venus-H-Ras-CAAX. HeLa cells were kept in an intracellular solution during the measurement. 
Permeabilization was achieved by adding digitonin (25 µg/ml, 5 min). Note the appearance of the 
fluorescent signal on the membrane of non-transfected cells in the case of Venus-K-Ras-CAAX, but not in 
Venus-H-Ras-CAAX. Cells are representatives of at least six measurements carried out in two independent 
experiments. 
(E) The effect of the combined PM and Golgi PPIns depletion on the BRET signal was measured between 
the Venus-K-Ras-CAAX and Golgi-Luc proteins (upper graph). In addition to these proteins, HEK 293T 
cells also expressed the proteins of the PM lipid depletion (PM-FRB-mRFP and mRFP-FKBP-PJ). To 
achieve a combined depletion of PtdIns4P also in the Golgi compartment (PM + Golgi PPIns depletion), 
cells were also transfected with TGN38-FRB-mRFP as an additional anchor of PJ on the surface of Golgi 
(see inset). For control TGN38-mRFP was used instead of TGN38-FRB-mRFP. BRET ratio values are 
expressed as difference between rapamycin treated and vehicle (DMSO) treated cells. In parallel, on the 
same plate, PM PtdIns(4,5)P2 levels was also measured. For this, cells expressed Venus and luciferase 
tagged PLCδ1-PH instead of Venus-K-Ras-CAAX and Golgi-Luc proteins. BRET ratio values were 
normalized by considering the resting ratio as 100% and the complete lack of energy transfer as 0% (see 
details of the calculation in Materials and Methods). Data are means ± SEM of three independent 
experiments. Statistical analysis were performed using t-test (*p < 0.05, **p < 0.01). 
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Figure 5. Effect of the isolated depletion of various types of PPIns on the K-Ras-CAAX translocation 
(A) To examine the effect of PM PtdIns(3,4,5)P3 on the K-Ras-CAAX translocation to the Golgi. BRET 
measurements were carried out on transiently transfected HEK 293T cells, expressing the required proteins 
(PM-FRB-mRFP and mRFP-FKBP-PJ) of the depletion system, and the Venus-K-Ras-CAAX and Golgi-
Luc proteins. PM PPIns was evoked by adding rapamycin (300 nM) or/and the PI3K inhibitor wortmannin 
(100 nM). The difference of the BRET ratios was calculated between the stimulated and vehicle (DMSO) 
treated cells. Data are means ± SEM of three independent experiments. Statistical analysis were performed 
using t-test in the case of the individual curves, and one way ANOVA was executed to examine the 
differences between the distinct treatments (*p < 0.05, **p < 0.01; ns, non-significant). 
(B) Effect of the solely PM PtdIns4P (green) or PtdIns(4,5)P2 (red) depletion compared to the joint (blue) 
depletion on the Venus-K-Ras-CAAX translocation to the Golgi, achieved via recruiting distinct specificity 
phosphatases (FKBP-PJ for PtdIns4P and PtdIns(4,5)P2; FKBP-PJ-Sac1 for PtdIns4P and FKBP-PJ-5ptase 
for PtdIns(4,5)P2 depletion) to the PM anchored FRB protein (PM-FRB-mRFP) by 300 nM rapamycin 
treatment. The experiments were carried out on transiently transfected HEK 293T cells. PM PPIns levels 
were also monitored simultaneously with translocation experiments using the same specific BRET based 
biosensors which were presented on Fig. 2C. The lipid changes were only plotted in the case of FKBP-
5ptase (red) or FKBP-4ptase (green). (The results of the joint depletion on the lipid pools were previously 
demonstrated also on the Fig. 2C.) The difference of the BRET ratios was calculated between rapamycin 
(300 nM) and vehicle (DMSO) treated cells. BRET ratio values were normalized by considering the resting 
ratio as 100% and the complete lack of energy transfer as 0% (see details of the calculation in Materials 
and Methods). Data are means ± SEM of four independent experiments. Statistical analysis were performed 
using t-test in the case of the individual curves, and one way ANOVA was executed to examine the 
differences between the different conditions (**p < 0.01, ***p < 0.001). 
 
Figure 6. Investigation of the localization of the constitutively active full-length forms of fluorescently 
tagged K- and H-Ras constructs after PM PPIns depletion 
(A) Schematic representation of the full-length K-and H-Ras-G12V constructs tagged with Venus 
fluorescent protein at the N-terminus. Confocal images show transiently transfected HEK 293T cells 
expressing the Venus tagged K-(left panel) or H-Ras-G12V (right panel) constructs and the proteins of the 
PPIns depletion system (PM-FRB and mRFP-FKBP-PJ, not visible). The images were collected before 
(left) and 5 min after the activation of the PM PPIns depletion system with 300 nM rapamycin. Cells are 
representatives of at least ten measurements carried out in three independent experiments. 
(B-C) Effect of the PM PPIns depletion on the K-Ras G12V or H-Ras G12V interaction with the 
endoplasmic reticulum or Golgi membrane (ER). BRET was measured between Venus tagged full-length 
Ras constructs and the same ER or Golgi targeted Luciferase protein as by the measurement on the Fig. 3C 
(ER-Luc on Panel B, and Golgi-Luc on Panel C). The measurements were carried out on transiently 
transfected HEK 293T cells expressing the indicated constructs for the BRET measurements and the 
proteins of the depletion system (PM-FRB-mRFP and mRFP-FKBP-PJ). BRET ratios were calculated 
between rapamycin (300 nM) and vehicle (DMSO) treated cells. Data are means ± SEM of three 
independent experiments. Statistical analysis were performed using t-test (*p < 0.05, ns, non-significant). 
 
Figure 7. Localization of the Venus-K-Ras-CAAX and Venus-K-Ras G12V constructs after PM PPIns 
depletion achieved via Gq-coupled 7-TM receptor activation 
(A) BRET measurements represent the interaction between the Venus-K-Ras-CAAX or Venus-K-Ras-
G12V constructs and Golgi targeted Luciferase (Golgi-Luc) after treating the cells with carbachol (10 μM) 
(blue plot). The specific inhibitor against PI4KA (responsible for PM PtdIns4P resynthesis) were also 
applied (A1 compound, in 10 nM concentration, 10 min pretreatment, red plot) in these experiments. The 
experiments were carried out on transiently transfected HEK 293T cells, which were expressing the wild 
type muscarinic M3 receptor to achieve sufficient PM PPIns depletion after carbachol treatment. The 
difference of the BRET ratios was calculated between carbachol (10 μM) treated and untreated cells. The 
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data are means ± SEM of three independent experiments. Statistical analysis were performed using t-test. 
Because of the different kinetic changes of the measurements without any pretreatment, t-test was also 
executed on the mean values of the three data points at the peak change (~1 min after stimulation) (*p < 
0.05, **p < 0.01, ns, non-significant). 
(B) Parallel confocal images from cells expressing the Venus-K-Ras-CAAX construct show the same 
experiments which were presented on the panel A on the top. To evaluate the changes on the Golgi, 
transiently transfected COS-7 cells were applied aiming better insight to this region of the cells. Left 
pictures show the control period, middle images were collected 1 min after carbachol (10 μM) treatment, 
and the right pictures represents the cells after 5 min of muscarinic receptor activation. Arrows indicate the 
position of the Golgi. The cells were expressing the wild type muscarinic M3 receptor, to achieve sufficient 
PM PPIns depletion after carbachol treatment (not visible). Cells are representatives of at least ten 
measurements carried out in three independent experiments. 
(C) BRET measurements represent the interaction between the Venus-K-Ras-CAAX construct and Golgi 
targeted Luciferase (Golgi-Luc) after treating the cells with EGF (100 ng/ml) (blue plot). Specific inhibitors 
against PI4KA (A1 compound, in 10 nM concentration, 10 min pretreatment, red plot) and against the PI3K 
(wortmannin -indicated as Wm- in 100 nM concentration, 10 min pretreatment, green plot) were also 
applied in these experiments. The experiments were carried out on transiently transfected HEK 293T cells, 
which were expressing the human EGF receptor to achieve sufficient PM PPIns depletion after EGF 
treatment. The difference of the BRET ratios was calculated between EGF (100 ng/ml) treated and untreated 
cells. The data are means ± SEM of four independent experiments. Statistical analysis were performed 
using t-test (**p < 0.01). 
  
Figure 8. Measurement of the radiolabeled [3H]-Leucine incorporation in distinct Ras mutants 
expressing cells with or without concomitant PM PPIns depletion 
(A) Evaluation of the normalized 24 hour [3H]-Leucine incorporation in transiently transfected COS-7 cells 
expressing the mRFP-tagged versions of the dominant negative S17N or constitutively active G12V forms 
of both K- and H-Ras proteins. Values were normalized to K-Ras S17N. Data are means ± SEM of three 
independent experiments. Statistical analysis was carried out using two-way ANOVA followed by Holm-
Sidak all pairwise multiple comparison method on the data of the four groups (***p<0.001). 
(B) Comparison of the normalized [3H]-Leucine incorporation in distinct Ras isoforms expressing cells 
with or without concomitant PM PPIns. The measurements were carried out on transiently transfected COS-
7 cells expressing the mRFP tagged versions of the indicated Ras isoforms and the required proteins of our 
PM PPIns depletion system (PM-FRB-mRFP and mRFP-FKBP-PJ). PM PPIns depletion was evoked by 
long term rapamycin treatment (100 nM, 24 hours, repeated in every 8 hours). For the control 
measurements, an enzymatically inactive form of the phosphatase was used (PJ-dead). Values were 
normalized to K-Ras S17N with PJ-dead recruitment. Data are means ± SEM of four independent 
experiments. Statistical analysis was carried out using two-way ANOVA followed by Holm-Sidak all 
pairwise multiple comparison method on the data of the four groups (**p < 0.01, ***p < 0.001, ns, non-
significant). 
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